Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2019, Vol. 13 Issue (1) : 121-125    https://doi.org/10.1007/s11684-018-0615-2
LETTER TO FRONTIERS OF MEDICINE
Effect of antitubercular treatment on the pregnancy outcomes and prognoses of patients with genital tuberculosis
Jing Yue1, Bo Zhang1, Mingyue Wang1, Junning Yao1, Yifan Zhou1, Ding Ma2, Lei Jin1()
1. Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2. Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
 Download: PDF(88 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

This retrospective study aims to demonstrate the effect of antitubercular treatment (ATT) on the pregnancy outcomes and prognoses of patients with genital tuberculosis (GTB) who had received laparoscopy and/or hysteroscopy. This study included 78 patients with infertility and who were diagnosed with GTB through laparoscopy and/or hysteroscopy over the period of November 2005 to October 2015. The recruited patients were divided into ATT and nonATT groups on the basis of ATT duration. The GTB recurrence rates, menstrual patterns, and pregnancy outcomes of the patients were determined at follow-up. Among the 78 patients, 46 received ATT and 32 did not receive ATT. The menstrual volumes of patients in the ATT group significantly decreased relative to those of patients in the nonATT group. GTB did not recur among all patients regardless of treatment. A total of 11 pregnancies (36.7%) in the ATT group and 19 pregnancies (63.3%) in the nonATT group were observed. Pregnancy rates significantly differed (P = 0.002) between the two groups. ATT may decrease the menstrual volume and pregnancy rates of patients who were diagnosed with GTB through laparoscopy and/or hysteroscopy. In addition, ATT did not improve the prognosis of patients with chronic GTB.

Keywords antitubercular treatment      pregnancy      prognosis      genital tuberculosis     
Corresponding Author(s): Lei Jin   
Just Accepted Date: 24 April 2018   Online First Date: 27 June 2018    Issue Date: 12 March 2019
 Cite this article:   
Jing Yue,Bo Zhang,Mingyue Wang, et al. Effect of antitubercular treatment on the pregnancy outcomes and prognoses of patients with genital tuberculosis[J]. Front. Med., 2019, 13(1): 121-125.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-018-0615-2
https://academic.hep.com.cn/fmd/EN/Y2019/V13/I1/121
Total ATT NonATT P value
No. % No. %
Total 78 46 59.0 32 41.0
Age (year) 0.515
<30 55 32 58.2 23 41.8
≥30 23 14 60.9 9 39.1
Infertility 0.669
Primary 73 43 58.9 30 41.1
Secondary 5 3 60.0 2 40.0
Endometrial biopsy 0.598
TB-positive 22 13 59.1 9 40.9
TB-negative 56 33 58.9 23 41.1
Hydrosalpinx 0.696
Yes 32 19 59.4 13 40.6
No 46 27 57.8 19 42.2
Salpingectomy 0.914
Bilateral 33 20 60.6 13 39.4
Unilateral 13 7 53.8 6 46.2
None 32 19 59.4 13 40.6
Pelvic adhesions 0.682
Yes 76 45 58.7 31 41.3
No 2 1 50.0 1 50.0
Chest X-ray 0.074
Positive 28 13 46.4 15 53.6
Negative 50 33 66.0 17 34.0
Tab.1  Patient characteristics
Before ATT After ATT
ATT NonATT P value ATT NonATT P value
Menstrual volume 0.447 0.007*
Normal 37 27 24 26
Less 9 5 22 6
Menstrual period 0.114 0.192
Regular 42 32 43 33
Non-regular 4 0 2 0
Tab.2  Comparison of the menstrual volumes and menstrual periods of patients in the two groups before and after ATT
No. ATT NonATT P value
Total 78 46 32
Recurrence
Yes 0 0 (0.0%) 0 (0.0%) a
No 78 46 (100.0%) 32 (100.0%)
Pregnant outcome 0.002*
Pregnancy 30 11 (36.7%) 19 (63.3%)
Nonpregnancy 48 35 (72.9%) 13 (27.1%)
Tab.3  Comparison of the prognoses and pregnancy outcomes of the two groups
1 GSchaefer. Female genital tuberculosis. Clin Obstet Gynecol 1976; 19(1): 223–239
https://doi.org/10.1097/00003081-197603000-00016 pmid: 1082803
2 PKMalkani, CK Rajani. Pelvic tuberculosis. Obstet Gynecol 1959; 14: 600–611
pmid: 14420334
3 ATinelli, A Malvasi, DVergara, RMartignago, GNicolardi, RTinelli, MPellegrino. Abdominopelvic tuberculosis in gynaecology: laparoscopical and new laboratory findings. Aust N Z J Obstet Gynaecol 2008; 48(1): 90–95
https://doi.org/10.1111/j.1479-828X.2007.00800.x pmid: 18275578
4 UNJindal, Y Bala, SSodhi, SVerma, SJindal. Female genital tuberculosis: early diagnosis by laparoscopy and endometrial polymerase chain reaction. Int J Tuberc Lung Dis 2010; 14(12): 1629–1634
pmid: 21144250
5 MEftekhar, S Pourmasumi, PSabeti, AAflatoonian, MHSheikhha. Mycobacterium tuberculosis infection in women with unexplained infertility. Int J Reprod Biomed (Yazd) 2015; 13(12): 749–754
pmid: 27141534
6 VBhanothu, JP Theophilus, PKReddy, RRozati. Occurrence of female genital tuberculosis among infertile women: a study from a tertiary maternal health care research centre in South India. Eur J Clin Microbiol Infect Dis 2014; 33(11): 1937–1949
https://doi.org/10.1007/s10096-014-2164-1 pmid: 24894340
7 JBSharma, J Sneha, UBSingh, SKumar, KKRoy, N Singh, SDharmendra, PVanamail. Comparative study of laparoscopic abdominopelvic and fallopian tube findings before and after antitubercular therapy in female genital tuberculosis with infertility. J Minim Invasive Gynecol 2016; 23(2): 215–222
https://doi.org/10.1016/j.jmig.2015.09.023 pmid: 26455527
8 JBSharma, J Sneha, UBSingh, SKumar, KKRoy, N Singh, SDharmendra, ESharma, ASharma. Effect of antitubercular therapy on endometrial function in infertile women with female genital tuberculosis. Infect Disord Drug Targets 2016; 16(2):101–108
pmid: 26694016
9 IKNeonakis, DA Spandidos, EPetinaki. Female genital tuberculosis: a review. Scand J Infect Dis 2011; 43(8): 564–572
https://doi.org/10.3109/00365548.2011.568523 pmid: 21438789
10 RDeans, J Abbott. Review of intrauterine adhesions. J Minim Invasive Gynecol 2010; 17(5): 555–569
https://doi.org/10.1016/j.jmig.2010.04.016 pmid: 20656564
11 UNJindal, S Verma, YBala. Favorable infertility outcomes following anti-tubercular treatment prescribed on the sole basis of a positive polymerase chain reaction test for endometrial tuberculosis. Hum Reprod 2012; 27(5): 1368–1374
https://doi.org/10.1093/humrep/des076 pmid: 22419745
12 UNJindal, Y Bala, SSodhi, SVerma, SJindal. Female genital tuberculosis: early diagnosis by laparoscopy and endometrial polymerase chain reaction. Int J Tuberc Lung Dis 2010; 14(12): 1629–1634
pmid: 21144250
13 TRana, UB Singh, VKulshrestha, AKaushik, CPorwal, NAgarwal, AKriplani. Utility of reverse transcriptase PCR and DNA-PCR in the diagnosis of female genital tuberculosis. J Med Microbiol 2011; 60(Pt 4): 486–491
https://doi.org/10.1099/jmm.0.025080-0 pmid: 21183595
14 FRParikh, SG Nadkarni, SAKamat, NNaik, SB Soonawala, RMParikh. Genital tuberculosis — a major pelvic factor causing infertility in Indian women. Fertil Steril 1997; 67(3): 497–500
https://doi.org/10.1016/S0015-0282(97)80076-3 pmid: 9091337
15 VKulshrestha, A Kriplani, NAgarwal, UBSingh, TRana. Genital tuberculosis among infertile women and fertility outcome after antitubercular therapy. Int J Gynaecol Obstet 2011; 113(3): 229–234
https://doi.org/10.1016/j.ijgo.2010.12.014 pmid: 21457984
16 ECaliskan, Y Cakiroglu, KSofuoglu, EDoger, MEAkar, SOOzkan. Effects of salpingectomy and antituberculosis treatments on fertility results in patients with genital tuberculosis. J Obstet Gynaecol Res 2014; 40(10): 2104–2109
https://doi.org/10.1111/jog.12450 pmid: 25131900
[1] Huanping Wang, Haitao Meng, Jinghan Wang, Yinjun Lou, Yile Zhou, Peipei Lin, Fenglin Li, Lin Liu, Huan Xu, Min Yang, Jie Jin. Clinical characteristics and prognostic values of 1p32.3 deletion detected through fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma: a single-center study in China[J]. Front. Med., 2020, 14(3): 327-334.
[2] Yanfei Zhang, Xinchun Zhao, Yongchun Zhou, Min Wang, Guangbiao Zhou. Identification of an E3 ligase-encoding gene RFWD3 in non-small cell lung cancer[J]. Front. Med., 2020, 14(3): 318-326.
[3] Yue Wang, Jinxia Zhang, Yunfan Wang, Shufang Wang, Yu Zhang, Qi Miao, Fei Gao, Huiying He. Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma[J]. Front. Med., 2019, 13(6): 730-740.
[4] Wenjing Wang, Shigang Ding, Hejun Zhang, Jun Li, Jun Zhan, Hongquan Zhang. G protein-coupled receptor LGR6 is an independent risk factor for colon adenocarcinoma[J]. Front. Med., 2019, 13(4): 482-491.
[5] Weiqi Rong, Yang Zhang, Lei Yang, Lin Feng, Baojun Wei, Fan Wu, Liming Wang, Yanning Gao, Shujun Cheng, Jianxiong Wu, Ting Xiao. Post-surgical resection prognostic value of combined OPN, MMP7, and PSG9 plasma biomarkers in hepatocellular carcinoma[J]. Front. Med., 2019, 13(2): 250-258.
[6] Yiwen Cao, Zhenhua Liu, Wen Wu, Ying Qian, Qin Shi, Rong Shen, Binshen Ouyang, Pengpeng Xu, Shu Cheng, Jin Ye, Yiming Lu, Chaofu Wang, Chengde Yang, Li Wang, Weili Zhao. Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma[J]. Front. Med., 2019, 13(1): 94-103.
[7] Sarah H. Alfaraj, Jaffar A. Al-Tawfiq, Talal A. Altuwaijri, Ziad A. Memish. Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia[J]. Front. Med., 2019, 13(1): 126-130.
[8] Bin Yang, Yan Yu, Jing Chen, Yan Zhang, Ye Yin, Nan Yu, Ge Chen, Shifei Zhu, Haiyan Huang, Yongqun Yuan, Jihui Ai, Xinyu Wang, Kezhen Li. Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely and successfully become pregnant---a Chinese retrospective cohort study among 148 cases[J]. Front. Med., 2018, 12(5): 509-517.
[9] Ye Yin, Ge Chen, Kezhen Li, Qiuyue Liao, Sijia Zhang, Nieying Ma, Jing Chen, Yan Zhang, Jihui Ai. Propensity score-matched study and meta-analysis of cumulative outcomes of day 2/3 versus day 5/6 embryo transfers[J]. Front. Med., 2017, 11(4): 563-569.
[10] Sasa Nie, Zhe Feng, Lihua Xia, Jiuxu Bai, Fenglin Xiao, Jian Liu, Li Tang, Xiangmei Chen. Risk factors of prognosis after acute kidney injury in hospitalized patients[J]. Front. Med., 2017, 11(3): 393-402.
[11] Changlin Cao, Jingxian Gu, Jingyao Zhang. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases[J]. Front. Med., 2017, 11(2): 169-177.
[12] Lei Huang,Aman Xu. Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination[J]. Front. Med., 2017, 11(1): 20-31.
[13] Xinsen Xu,Yanyan Zhou,Runchen Miao,Wei Chen,Kai Qu,Qing Pang,Chang Liu. Transcriptional modules related to hepatocellular carcinoma survival: coexpression network analysis[J]. Front. Med., 2016, 10(2): 183-190.
[14] Zhi Xu,Chunxiang Cao,Haiyan Xia,Shujing Shi,Lingzhi Hong,Xiaowei Wei,Dongying Gu,Jianmin Bian,Zijun Liu,Wenbin Huang,Yixin Zhang,Song He,Nikki Pui-Yue Lee,Jinfei Chen. Protein phosphatase magnesium-dependent 1δ is a novel tumor marker and target in hepatocellular carcinoma[J]. Front. Med., 2016, 10(1): 52-60.
[15] Aixiu Qiao,Feng Gu,Xiaojing Guo,Xinmin Zhang,Li Fu. Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications[J]. Front. Med., 2016, 10(1): 33-40.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed